ASCO 2017 Efficacy of Enzalutamide post Abiraterone (PDF | 251 KB )
ASCO GU 2017_Prostate Cancer Registry: Therapeutical 1st-line Comparison (PDF | 252 KB )
ASCO GU 2017: Abiraterone vs Docetaxel in metastatic HormonSensitive PCa (PDF | 251 KB )
ESMO 2017: Comparison of Abiraterone, Prednisone and Docetaxel for mHSPC (PDF | 296 KB )
ESMO 2017_CUREVAC: Results of mRNA-based Immunotherapy in mHRPC, Phase IIIb (PDF | 116 KB )
ASCO 2016_Prostate Cancer Registry: M-Stage at Diagnosis (PDF | 710 KB )
EMUC 2016_IMPACT: Influence of Adherence Measures on Abiraterone (PDF | 3.0 MB )
ECC / ESMO 2015_SYNERGY: Docetaxel +/- Custirsen (PDF | 742 KB )
ASCO-GU-2015_COMET-1: Cabozantinib vs Prednisone in mCRPC-Patients Previously Treated with Docetaxel and Abi / Enza (PDF | 10.0 MB )
ECC 2015_Registry: Prospective, Observational Study in mCRPC (PDF | 791 KB )
ASCO GU 2015_Steroid Study: Abiraterone plus 1 of 4 Glucocorticoid Regimens in mCRPC (PDF | 369 KB )
